How I treat hemochromatosis.

James C Barton, Paul C Adams

Journal: Blood 2010;116(3):317-25

PMID: 20308595

Free Full Text on Elsevier Science View on PubMed

Abstract

Hemochromatosis is a common genetic disorder in which iron may progressively accumulate in the liver, heart, and other organs. The primary goal of therapy is iron depletion to normalize body iron stores and to prevent or decrease organ dysfunction. The primary therapy to normalize iron stores is phlebotomy. In this opinion article, we discuss the indications for and monitoring of phlebotomy therapy to achieve iron depletion, maintenance therapy, dietary and pharmacologic maneuvers that could reduce iron absorption, and the role of voluntary blood donation.

Address: University Hospital, University of Western Ontario, London, ON, Canada. [email protected]

DOI: 10.1182/blood-2010-01-261875

Link outs

Free resources

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0006...

Medical:

https://medlineplus.gov/hemochromatosis.html

Subscription / membership required

Full Text Sources:

https://ashpublications.org/blood/article-lookup/d...

MeSH Terms: Blood Donors, Chelation Therapy, Cytapheresis, Deferoxamine, Female, Hemochromatosis, Hemochromatosis Protein, Histocompatibility Antigens Class I, Homozygote, Humans, Iron, Iron, Dietary, Male, Membrane Proteins, Phlebotomy, Proton Pump Inhibitors, Siderophores